Publicaciones en colaboración con investigadores/as de John Radcliffe Hospital (40)

2024

  1. Coronary Physiology as Part of a State-of-the-Art Percutaneous Coronary Intervention Strategy: Lessons from SYNTAX II and Beyond

    Cardiology Clinics, Vol. 42, Núm. 1, pp. 147-158

  2. Sex ratio and age of onset in AQP4 antibody-associated NMOSD: a review and meta-analysis

    Journal of Neurology, Vol. 271, Núm. 8, pp. 4794-4812

2023

  1. A second update on mapping the human genetic architecture of COVID-19

    Nature

  2. Coronary Physiology as Part of a State-of-the-Art Percutaneous Coronary Intervention Strategy: Lessons from SYNTAX II and Beyond

    Interventional Cardiology Clinics, Vol. 12, Núm. 1, pp. 141-153

  3. Factors associated with the severity of COVID-19 outcomes in people with neuromuscular diseases: Data from the International Neuromuscular COVID-19 Registry

    European Journal of Neurology, Vol. 30, Núm. 2, pp. 399-412

  4. Ravulizumab in Aquaporin-4–Positive Neuromyelitis Optica Spectrum Disorder

    Annals of Neurology, Vol. 93, Núm. 6, pp. 1053-1068

2022

  1. Eculizumab monotherapy for NMOSD: Data from PREVENT and its open-label extension

    Multiple Sclerosis Journal, Vol. 28, Núm. 3, pp. 480-486

  2. Five-year outcomes after state-of-the-art percutaneous coronary revascularization in patients with de novo three-vessel disease: Final results of the SYNTAX II study

    European Heart Journal, Vol. 43, Núm. 13, pp. 1307-1316

2021

  1. Long-Term Safety and Efficacy of Eculizumab in Aquaporin-4 IgG-Positive NMOSD

    Annals of Neurology, Vol. 89, Núm. 6, pp. 1088-1098

  2. Quantifying duration of proteinuria remission and association with clinical outcome in IgA nephropathy

    Journal of the American Society of Nephrology, Vol. 32, Núm. 2

2020

  1. Two years clinical outcomes with the state-of-the-art PCI for the treatment of bifurcation lesions: A sub-analysis of the SYNTAX II study

    Catheterization and Cardiovascular Interventions, Vol. 96, Núm. 1, pp. 10-17

2019

  1. Angiography-Derived Fractional Flow Reserve in the SYNTAX II Trial: Feasibility, Diagnostic Performance of Quantitative Flow Ratio, and Clinical Prognostic Value of Functional SYNTAX Score Derived From Quantitative Flow Ratio in Patients With 3-Vessel Disease

    JACC: Cardiovascular Interventions, Vol. 12, Núm. 3, pp. 259-270

  2. Clinical Events After Deferral of LAD Revascularization Following Physiological Coronary Assessment

    Journal of the American College of Cardiology, Vol. 73, Núm. 4, pp. 444-453

  3. Clinical Implication of Quantitative Flow Ratio After Percutaneous Coronary Intervention for 3-Vessel Disease

    JACC: Cardiovascular Interventions, Vol. 12, Núm. 20, pp. 2064-2075

  4. Clinical outcomes of state-of-the-art percutaneous coronary revascularisation in patients with three-vessel disease: Twoyear follow-up of the SYNTAX II study

    EuroIntervention, Vol. 15, Núm. 3, pp. E244-A252

  5. Comparison of Major Adverse Cardiac Events between Instantaneous Wave-Free Ratio and Fractional Flow Reserve-Guided Strategy in Patients with or Without Type 2 Diabetes: A Secondary Analysis of a Randomized Clinical Trial

    JAMA Cardiology, Vol. 4, Núm. 9, pp. 857-864

  6. Impact of post-procedural minimal stent area on 2-year clinical outcomes in the SYNTAX II trial

    Catheterization and Cardiovascular Interventions, Vol. 93, Núm. 4, pp. E225-E234

2018

  1. Fractional Flow Reserve Derived From Computed Tomographic Angiography in Patients With Multivessel CAD

    Journal of the American College of Cardiology, Vol. 71, Núm. 24, pp. 2756-2769

  2. Safety of the Deferral of Coronary Revascularization on the Basis of Instantaneous Wave-Free Ratio and Fractional Flow Reserve Measurements in Stable Coronary Artery Disease and Acute Coronary Syndromes

    JACC: Cardiovascular Interventions, Vol. 11, Núm. 15, pp. 1437-1449

2017

  1. Clinical outcomes of state-of-the-art percutaneous coronary revascularization in patients with de novo three vessel disease: 1-year results of the SYNTAX II study

    European Heart Journal, Vol. 38, Núm. 42, pp. 3124-3134